Frazer Institute

ODeSI – Operational Research and Decision Support for Prevention, Control and Elimination of Infectious Diseases

Innovation to reduce the global burden of infectious disease

We aim to optimise infectious disease prevention, control, and elimination by generating new evidence and providing innovative solutions that support clinical and public health decision making.

Our team develops strong multidisciplinary partnerships with clinical and public health decision makers to co-create and design research questions and programs, collaborate on the implementation and evaluation of research interventions, and explore the application of innovative methods and new technologies to disease prevention and control.

We have extensive experience with infectious diseases and clinical epidemiology, with a focus on neglected tropical diseases, emerging infectious diseases, antimicrobial resistance, vaccine-preventable diseases, travel medicine, global health, digital health, and implementation science. Our team members have expertise in operational research and field surveys, predictive risk mapping and modelling (spatial epidemiology), clinical trials, disease surveillance, systematic reviews and meta-analyses, and the use of novel methods to aid inference, including Bayesian network, machine learning, social network analysis and dynamic data visualisation tools.

Subject expertise

  • Neglected Tropical Diseases – lymphatic filariasis & others
  • Emerging Infectious Diseases – leptospirosis, arboviruses, & others
  • Travel medicine –malaria prophylaxis, vaccines, health & wellbeing of travellers
  • Other infectious diseases

Methodological expertise

  • Field surveys – electronic data collection & management, field laboratories
  • Spatial epidemiology & predictive risk mapping & modelling
  • Eco-epidemiology – environmental & sociodemographic drivers of disease transmission
  • Clinical epidemiology, including clinical trials in travel clinic settings
  • Surveillance
  • Systematic reviews & meta-analyses
  • Bayesian networks
  • Novel epidemiological methods – machine learning, social network analyss, interactive & dynamic data visualisation tools

Neglected tropical diseases

Project

Funder

ID-NET team member(s)

Building Decision Support Systems to Combat Emerging Infectious Diseases and Neglected Tropical Diseases: A Precision Public Health Approach (2021-2025)
NHMRC Investigator Grants
Colleen Lau (CIA)
Australian Centre for the Control and Elimination of Neglected Tropical Diseases (ACE-NTD)
NHMRC Centre for Research Excellence
Colleen Lau (AI)
Angela Cadavid Restrepo
Helen Mayfield
Control of Neglected Tropical Diseases in the Pacific: integration of programs to increase their impact
NHMRC Partnership Grant
Colleen Lau (CI)
SaMELFS: Surveillance and Monitoring to Eliminate Lymphatic Filariasis and Scabies from Samoa
Task Force for Global Health
Colleen Lau (CIA)
Helen Mayfield
Transmission Strengthening Survey in American Samoa
Task Force for Global Health
Colleen Lau (CIA)
Angela Cadavid Restrepo
Follow up of Mf positive people
Integrated Surveillance of Neglected Tropical Diseases and Vaccine Preventable Diseases in Samoa
ACE-NTD NHMRC Centres for Research Excellence
Angela Cadavid Restrepo
Colleen Lau
Helen Mayfield
PoolTestR

Emerging infectious diseases

Project
Funder
ID-NET team member(s)
Building Decision Support Systems to Combat Emerging Infectious Diseases and Neglected Tropical Diseases: A Precision Public Health Approach (2021-2025)
NHMRC Investigator Grants
Colleen Lau (CIA)
APPRISE – an NHMRC Centre for Research Excellence
Colleen Lau (CIA)
Amalie Dyda
Lisa McHugh
SMART (Towards Systematic Maturation of Analytics and System Redesign to Transform Healthcare and Public Health Research). Decision Support Tools for COVID-19 Vaccination Rollout.
UQ Stimulus Grants
Colleen Lau
Amalie Dyda
Colleen Lau (CI)
Mathematical Models of Diseases with Complex Transmission Routes
ARC Project Grants
Colleen Lau (CI)
Defining the pathogens, transmission characteristics, risk factors and geospatial hotspots of acute febrile illnesses in the Dominican Republic.
US Centres for Disease Control and Prevention
Colleen Lau (CI)

Travel medicine and vaccinations

Project

Funder

ID-NET team member(s)

CoRiCal: COVID Risk Calculator Risk-benefit analysis of COVID-19 vaccines

Immunisation Coalition

Colleen Lau

Helen Mayfield

SMART (Towards Systematic Maturation of Analytics and System Redesign to Transform Healthcare and Public Health Research). Decision Support Tools for COVID-19 Vaccination Rollout.

UQ Stimulus Grants

Colleen Lau

Amalie Dyda

Japanese Encephalitis Vaccination via the IntraDermal route

International Society of Travel Medicine

Luis Furuya-Kanamori

Deborah Mills

Colleen Lau

Boostability of One priming dose IM Rabies vaccine especially in Senior age groups

Sanofi Pasteur

Deborah Mills

Luis Furuya-Kanamori

Colleen Lau

Travellers Rabies Intra Dermal Later testing & boosting

Sanofi Pasteur

Deborah Mills

Luis Furuya-Kanamori

Colleen Lau

Effect of multiple rabies booster doses in antibody titre level and recommended interval between booster doses for people with ongoing occupational exposure

CRESTMA

Deborah Mills

Luis Furuya-Kanamori

Colleen Lau

Links2HealthierBub: population-based data linkage project investigating the uptake, safety and effectiveness of vaccines in pregnancy

NHMRC Project Grant

Lisa McHugh (CI)

Adjuncts

Affiliates

Current students

  • Dr Beatris Martin (PhD, UQ Centre for Clinical Research): Spatio-temporal epidemiology of vector-borne diseases in the Dominican Republic
  • Wondimeneh Shiferaw (PhD, UQ Centre for Clinical Research): Assessing risk of importation of sexually transmitted infections into Australia by international travellers
  • Selina Ward (PhD, UQ Centre for Clinical Research) - Integrated Surveillance of Neglected Tropical Diseases and Vaccine-Preventable Diseases
  • Thomas Callaghan (PhD, UQ School of Veterinary Sciences): A big data food-chain approach to the epidemiology of zoonotic foodborne illness in Queensland
  • Nicky Foxlee (PhD, ANU School of Population Health, NCEPH): Developing Pathways to Improving Antibiotic Stewardship in Vanuatu
  • Jemma Rowlands (PhD, School of Public Health): Enhancing infectious disease surveillance through the integration of routinely collected data
  • Jane Sinclair (PhD, UQ School of Chemistry and Molecular Biosciences): The long-term cardiovascular complications of COVID-19
  • Ama Wakwella (PhD, UQ Centre for Biodiversity and Conservation Science): Delivering human and ecosystem health co‐benefits through integrated watershed management: improving disease prevention, fisheries, and marine environments in Fiji
  • Dr Sophie Wen (PhD, UQ Medical School): Gram negative blood stream infections in children
  • Kim Dianne Ligue (PhD, UQ Centre for Clinical Research): Using Machine Learning for Epidemiological Research on the African Swine Fever Epidemic in the Philippines
  • Holly Jian (Visiting Research Student, Masters of Applied Epidemiology, ANU School of Population Health, NCEPH) 
  • Fan Yu (PhD, UQ Centre for Clinical Research): Epidemiology and burden of rotavirus infections in Australia
  • Jin Cao (PhD, Child Health Research Centre): Climate and Environmental Change, Water Security, and Children's Vulnerability
  • Amar Teeluck (PhD, UQ Centre for Clinical Research): Modelling the Effect of a Changing Climate on the Re-emergence of Mosquito Borne Diseases in Mauritius
  • Indah Amelia (PhD, UQ Centre for Clinical Research): Integration of serological surveillance for Vaccine-Preventable Diseases and Non Communicable Diseases into national health screening program in Indonesia
  • Gabriel Parker (PhD, UQ Centre for Clinical Research): Quantifying Climate Changes Impact on Infectious Disease Burden in Queensland
  • Alemu Belete (PhD, UQ Centre for Clinical Research): Investigating the effect of climatic change on malaria in Ethiopia: A focus on distribution and transmission dynamics, persistence, adaptation strategies and public health intervention

We collaborate with a variety of partner organisations. These include the World Health Organization, US Centers for Disease Control and Prevention, Ministries of Health and governments, and many leading universities and research institutions including Harvard, Yale, and London School of Hygiene & Tropical Medicine.

Australian partners include:

We have a number of current international study partnerships in Samoa, American Samoa, Fiji, and the Dominican Republic.

International partners include:

Across our research team we have multiple student research projects available. Some examples are listed below, but please feel free to contact our team to discuss other options.

Higher Degree by Research - Available projects

Professor Colleen Lau

  • Integrated surveillance of neglected tropical diseases and vaccine preventable diseases in Samoa
  • Epidemiology of notifiable diseases in Australia
  • Vaccine preventable diseases in travellers
  • Decision support tools for COVID-19 vaccines

Associate Professor Benn Sartorius

Associate Professor Benn Sartorius (and Dr Jessica Chellappah, ADF)

  • Longitudinal tracking of cardiovascular disease and diabetes risk factors among Papua New Guinea (PNG) Defence Force from different locations within PNG.

Research and decision support tools

Japanese encephalitis vaccine risk-benefit tool (JET) for travellers

JET is an interactive, scenario-based online application that encompasses traveller’s characteristics and itinerary details to quantify the travellers risk of acquiring Japanese encephalitis infection and developing clinical symptoms with and without the vaccine, and experiencing an adverse events following immunisation.

Related publications

Colleen L Lau; Deborah J Mills; Helen Mayfield; Narayan Gyawali; Brian Johnson; Hongen Lu; Kasim Allel; Philip N Britton; Weiping Ling; Tina Moghaddam; Luis Furuya-Kanamori, "A decision support tool for risk-benefit analysis of Japanese encephalitis vaccine in travellers", Journal of Travel Medicine, 2023 Nov 18;30(7):taad113, doi: 10.1093/jtm/taad113

Side effect calculator for Japanese encephalitis vaccine

The Side effect calculator for Japanese encephalitis vaccine estimates the risk of adverse events following immunisation in concomitant administration of Japanese encephalitis and other vaccines. It is an interactive, scenario-based online application that encompasses age group, sex, JE vaccine and vaccine to be co-administered to estimate the risk of adverse events following immunisations.

PoolTestR package for estimating prevalence in pooled samples

The poolTestR R package, developed by Angus McLure, lets you easily analyse your data on pooled  samples, such as a tube of mosquitoes, to estimate the prevalence of a disease in your overall sample. With just a few lines of R code you can estimate infection prevalence in vectors, even from large and complex molecular xeno monitoring surveys across many sampling sites and vector species, split by however many levels you like. This means you can quickly compare the results between sites, villages, regions, time, or species. You can read more about how and why the software was developed on this COR-NTD blog post.

Related publications

McLure, A., O'Neill, B., Mayfield, H., Lau, C. & McPherson, B. PoolTestR: An R package for estimating prevalence and regression modelling for molecular xenomonitoring and other applications with pooled samples. Environmental Modelling & Software 145, 105158, doi:https://doi.org/10.1016/j.envsoft.2021.105158 (2021).

CoRiCAL COVID-19 vaccine risk-benefit calculator

The CoRiCAL COVID-19 vaccine risk-benefit calculator, hosted by the Immunisation Coalition, combines the latest evidence on the benefits of being vaccinated against COVID-19 compared to the risks from vaccines. The webpage is powered by a Bayesian Network model than combines results from published studies with Government published reports and knowledge from medical experts. CoRiCAL is the result of a dedicated team of academics and medical practitioners who collate and present the evidence into a user-friendly format to help people make an informed choice on vaccination.  It’s updated regularly to account for new evidence, vaccines and COVID-19 variants and is feely available from the IC website.

Related publications

Lau, C. L. et al. Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework. Vaccine, doi: https://doi.org/10.1016/j.vaccine.2021.10.079 (2021).

Sinclair, J. E. et al. Quantifying the risks versus benefits of the Pfizer COVID-19 vaccine in Australia: a Bayesian network analysis. medRxiv, 2022.2002.2007.22270637, doi:10.1101/2022.02.07.22270637 (2022).

Mayfield, H. J. et al. Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine. Vaccine 40, 3072-3084, doi: https://doi.org/10.1016/j.vaccine.2022.04.004 (2022).

CRISPER COVID-19 Real-time information system for preparedness and epidemic response

CRISPER is an interactive dashboard that provides accurate and spatially explicit real-time information for COVID-19 cases, deaths, testing and contact tracing locations in Australia. Developed based on feedback from key users and stakeholders, the system comprises three main components: (1) a data engine; (2) data visualization and interactive mapping tools; and (3) an automated alert system. The system provides integrated data from multiple sources in one platform which optimizes information sharing with public health responders, primary health care practitioners and the general public.

Related publications

Field E, Dyda A, Hewett M, Weng H, Shi J, Curtis S, Law C, McHugh L, Sheel M, Moore J, Furuya-Kanamori L, Pillai P, Konings P, Purcell M, Stocks N, Williams G, Lau CL. Development of the COVID-19 Real-time Information System for Preparedness and Epidemic Response (CRISPER), Australia. https://doi.org/10.3389/fpubh.2021.753493 (2021).

Field E, Dyda A, Lau CL. COVID‐19 Real‐time Information System for Preparedness and Epidemic Response (CRISPER). doi: 10.5694/mja2.51019 (2021).

Publications

Travel medicine and vaccines

Muttucumaru R, Lau CL, Leeb A, Mills DJ, Wood N, Furuya-Kanamori L. Post-marketing surveillance of 10,392 herpes zoster vaccines doses in Australia. Vaccine, Volume 42, Issue 13, 2024, Pages 3166-3171, ISSN 0264-410X, https://doi.org/10.1016/j.vaccine.2024.03.066.

Robert Steffen, Davidson H Hamer, Lin H Chen, Eric Caumes, Colleen L Lau, Novel chikungunya and dengue vaccines—travel medicine applications, Journal of Travel Medicine, 2024;, taae064, https://doi.org/10.1093/jtm/taae064

Zhu, Y., Mills, D.J., Mills, C., Lau, C.L., Furuya-Kanamori, L., 2024. Use of Dengvaxia® in Australian Travellers: a case series. Journal of Travel Medicine.. https://doi.org/10.1093/jtm/taae052 

Zhu, Y., Restrepo, A.C., Wang, H.-B., Mills, D.J., Liang, R.-R., Liu, Z.-B., Lau, C.L., Furuya-Kanamori, L., 2024. Malaria cases in China acquired through international travel, 2013–2022. Journal of Travel Medicine. https://doi.org/10.1093/jtm/taae056

Shiferaw W, Dean JA, Mills D, Lau C, Furuya-Kanamori L. Definition and classification of “travellers” in research: A bibliometric analysis. Journal of Travel Medicine 2024

Shiferaw, W. S., Martin, B.M., Dean, J.A., Mills, D., Lau, C., Paterson, D., Koh, K., Eriksson, L., Furuya-Kanamori, L. A systematic review and meta-analysis of sexually transmitted infections and blood-borne viruses in travellers. Journal of Travel Medicine, 2024.

Kasim Allel, Miguel M Cabada, Collen Lau, Deborah Mills, Richard C Franklin, Yan Zhu, Luis Furuya-Kanamori, Causes of death among international travellers in Peru, 2017 to 2021, Journal of Travel Medicine, Volume 31, Issue 1, January 2024, taad163, https://doi.org/10.1093/jtm/taad163

Santoalaya C, Malhotra J, Fowler JA, Warzywoda S, Debattista J, Mills DJ, Lau C, Furuya-Kanamori L, et al. Sexual and reproductive health integration into pre-travel consultations: a scoping review. Journal of Travel Medicine. 2024.

Furuya-Kanamori L, Mills DJ, Zhu Y, Lau CL. Can a single visit rabies pre-exposure prophylaxis eliminate the need for rabies immunoglobulin in last minute travellers? Journal of Travel Medicine. 2023;30(8).

Kasim Allel, Miguel M Cabada, Collen Lau, Deborah Mills, Richard C Franklin, Yan Zhu, Luis Furuya-Kanamori. Causes of death among international travellers in Peru, 2017 to 2021, Journal of Travel Medicine, 2023; taad163, https://doi.org/10.1093/jtm/taad163

Warzywoda S, Fowler JA, Debattista J, Mills DJ, Furuya-Kanamori L, Durham J, Lau CL., Mullens AB, et al. The provision of sexual and reproductive health information and services to travellers: an exploratory survey of Australian travel medicine clinicians. Sexual Health. 2024;21(1). https://www.publish.csiro.au/sh/Fulltext/SH23098

Franklin R, Lau C. Vale Emeritus Professor Peter A Leggat. Travel Medicine and Infectious Disease. 2024;57:102683. https://doi.org/10.1016/j.tmaid.2023.102683

Rafferty AC, Bofkin K, Hughes W, Souter S, Hosegood I, Hall RN, Furuya-Kanamori L, Liu B, Regan T, Drane M, Halder M, Kelaher C, Kirk M. Does 2x2 airplane passenger contact tracing for infectious respiratory pathogens work? A systematic review of the evidence. PLoS One 2023; [Epub ahead of print]

McGuinness, S. L., Lau, C. L., & Leder, K. (2023). Co-circulation of Murray-Valley Encephalitis Virus and Japanese Encephalitis Virus in south-eastern Australia. Journal of Travel Medicine. doi:10.1093/jtm/taad059

Guo, Y., Mills, D. J., Lau, C. L., Mills, C., & Furuya‐Kanamori, L. (2023). Immune response after rabies pre‐exposure prophylaxis and a booster dose in Australian bat carers. Zoonoses and Public Health. doi:10.1111/zph.13048

Furuya-Kanamori L, Gyawali N, Mills DJ, Hugo LE, Devine GJ, Lau CL. The Emergence of Japanese Encephalitis in Australia and the Implications for a Vaccination Strategy. Tropical Medicine and Infectious Disease. 2022;7(6).

Sinclair JE, Mayfield HJ, Short KR, Brown SJ, Puranik R, Mengersen K, Litt JCB, Lau CL. A Bayesian network analysis quantifying risks versus benefits of the Pfizer COVID-19 vaccine in Australia, npj Vaccines

Laith Yakob, PhD, Wenbiao Hu, PhD, Francesca D Frentiu, PhD, Narayan Gyawali, PhD, Leon E Hugo, PhD, Brian Johnson, PhD, Colleen Lau, MBBS, PhD, Luis Furuya-Kanamori, MBBS, PhD, Ricardo Soares Magalhaes, LMV, PhD, Gregor Devine, PhD, Japanese encephalitis emergence in Australia: the potential population at risk, Clinical Infectious Diseases, 2022;, ciac794, https://doi.org/10.1093/cid/ciac794

Luis Furuya-Kanamori, PhD, Narayan Gyawali, PhD, Deborah J Mills MBBS MPHTM, Christine Mills, BSc, Leon E Hugo, PhD, Gregor J Devine, PhD, Colleen L Lau, MBBS, Immunogenicity of a single fractional intradermal dose of Japanese encephalitis live attenuated chimeric vaccine, Journal of Travel Medicine, 2022, https://doi.org/10.1093/jtm/taac122

McHugh L,  Van Buynder P, Sarna M, Andrews RM, Moore HC, Binks MJ, Pereira G, Blyth CC, Lust K, Foo D, Regan AK. Timing and temporal trends of influenza and pertussis vaccinations during pregnancy in three Australian jurisdictions: The Links2HealthierBubs population-based linked cohort study, 2012–2017. ANZJOG. 2022; Epub13June 2022. doi.org/10.1111/ajo.13548.

Wattiaux AL, May F, Allen T, Bladen T, Pery B, McHugh L, Slinko V, Sykes A, De Silva L, Bajra J, Andrews R, Khandaker G. Defining the peak: Point prevalence of SARS-CoV-2 using randomised sampling. Comm Diseases Intel.2022;46.doi: 10.33321/cdi.2022.46.24. Epub 26/4/2022

Homaira N, Binks M, Walker G, Larter N, Clark K, Campbell M, McHugh L, Briggs N, Nyiro J, Stelzer-Braid S, Hu N, Macartney K,Snelling T, Omer SB, Rawlinson W, Andrews R, Jaffe A.Transplacental transfer of RSV antibody in Australian First Nations infants. (Short communication) Journal of Medical Virology. 2021. doi: 10.1002/jmv.27383

Furuya-Kanamori L, Xu C, Doi SAR, Clark J, Wangdi K, Mills DJ, Lau CL. Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis. Vaccine. 2021;39(32):4429-36. doi: https://doi.org/10.1016/j.vaccine.2021.06.023.

McHugh L, O’Grady KA-F, Nolan T, Richmond PC, Wood N, Marshall HS, Lambert SB,  Chatfield MD, Paula Binks, Binks MJ, Andrews RM. 2021. National predictors of influenza vaccine uptake in pregnancy: The FluMum study, Australia, 2012-2015. Australian & New Zealand Journal of Obstetrics & Gynaecology. 45(5): 455-61. doi: https://doi.org/10.1111/1753-6405.13130

Mills DJ, Lau CL, Mills C, Furuya-Kanamori L. Efficacy of one-dose intramuscular rabies vaccine as pre-exposure prophylaxis in travellers. Journal of Travel Medicine. 2021;28(5). doi: 10.1093/jtm/taab059. 

Ling W, Doi SAR, Lau CL, Mills DJ, Kostoulas P, Furuya-Kanamori L. Diagnostic accuracy of ELISA kits for measurement of rabies antibodies. Journal of Travel Medicine. 2021;28(5). doi: 10.1093/jtm/taab060.

Islam N, Wright S, Lau CL, Doi SAR, Mills DJ, Clark J, Clements ACA, Furuya-Kanamori L. Efficacy of a 3-day pretravel schedule of tafenoquine for malaria chemoprophylaxis: a network meta-analysis. Journal of Travel Medicine. 2021;28(5). doi: 10.1093/jtm/taab057.

Xu C, Lau CL, Clark J, Rafferty AC, Mills DJ, Ramsey L, Gilbert B, Doi SAR, Furuya-Kanamori L. Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis. Vaccine. 2021;39(7):1044-50. doi: https://doi.org/10.1016/j.vaccine.2021.01.023.

Furuya-Kanamori L, Dutton P, Leeb A, Mills DJ, Andrews R, Lau CL. Adverse Events Following Immunization With Combined vs Concurrent Monovalent Hepatitis A and Typhoid Vaccines in Children. Journal of the Pediatric Infectious Diseases Society. 2020;10(2):192-5. doi: 10.1093/jpids/piaa031.

Furuya-Kanamori L, Mills DJ, Lau CL. Could intradermal be an economical alternative route of administration for Japanese encephalitis vaccines? Journal of Travel Medicine. 2020;28(1). doi: 10.1093/jtm/taaa181.

McFadden K, Heywood A, Dyda A, Kaufman J, Seale H. Minimising missed opportunities to promote and deliver immunization services to middle and older age adults: Can hospital-based programs be a solution? Vaccine. 2021;39(26):3467-72. Epub 2021/05/25. doi: 10.1016/j.vaccine.2021.05.027. PubMed PMID: 34024659.

Heywood A, Dyda A, Hu W, Saha A, Mahimbo A, Gidding H, Kefalas B, Seale H, Macintyre CR, Zwar N, Rawlinson W. Seroprevalence of hepatitis B antibodies among international and domestic university students. Journal of Viral Hepatitis. 2021;28(10):1400-12. doi: https://doi.org/10.1111/jvh.13580.

Furuya-Kanamori L, Mills DJ, Trembizki E, Robson JM, Jennison AV, Whiley DM, Lau CL. High rate of asymptomatic colonization with antimicrobial-resistant Escherichia coli in Australian returned travellers. J Travel Med. 2022;29(1). Epub 2021/09/09. doi: 10.1093/jtm/taab141. PubMed PMID: 34494119.

Wen SCH, Ezure Y, Rolley L, Spurling G, Lau CL, Riaz S, Paterson DL, Irwin AD. Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis. PLOS Medicine. 2021;18(9):e1003787. doi: 10.1371/journal.pmed.1003787.

Mills DJ, Lau CL, Mills C, Furuya-Kanamori L. Long-term persistence of antibodies and boostability after rabies intradermal pre-exposure prophylaxis. Journal of Travel Medicine. 2021. doi: 10.1093/jtm/taab188.

Dyda A, Purcell M, Curtis S, Field E, Pillai P, Ricardo K, Weng H, Moore JC, Hewett M, Williams G, Lau CL. Differential privacy for public health data: An innovative tool to optimize information sharing while protecting data confidentiality. doi: 10.1016/j.patter.2021.100366 (2021).

Emerging infectious diseases

Martin, B.M., Cadavid Restrepo, A. M., Mayfield, H., Lau, C.L. Towards Global Elimination of Lymphatic Filariasis – A Systematic Review of the Applications of Spatial Epidemiological Methods to Enhance Surveillance and Support Elimination Programs. BML Public Health, 2024.

Heryanto, B., Prasettya Japri, A., Craig, A.T. Community-based surveillance (CBS) review in Indonesia. 2024. Australia Indonesia Health Security Partnership: Jakarta, Indonesia.

Sartorius B, Gray AP, Weaver ND, Aguilar GR, Swetschinski LR, Ikuta KS, Mestrovic T, Chung E, Wool EE, Han C, Hayoon AG. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis. The Lancet Global Health. 2023 Dec 19. DOI: https://doi.org/10.1016/S2214-109X(23)00539-9.

Sartorius K, Sartorius B, Winkler C, Chuturgoon A, Shen TW, Zhao Y, An P. Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study. International Journal of Molecular Sciences. 2024 Jan 12;25(2):975. DOI: https://doi.org/10.3390/ijms25020975.

Munazza Fatima, Ibtisam Butt, Neda Firouraghi, Maria Khalil, Behzad Kiani. Space-time analysis of tuberculosis (2016-2020) in South Punjab, Pakistan,  GeoJournal, 2024; http://dx.doi.org/10.1007/s10708-024-11020-x

Dove, G.; Kelly-Hanku, A.; Usurup, J.; O’Keeffe, A.; Scahill, G.; Craig, A. Collaboration in a partnership for primary health care: a case study from Papua New Guinea. Global Health: Science and Practice, (in press), 2023.

Sarah L. McGuinness, Colleen Lau, Karin Leder, The evolving Japanese encephalitis situation in Australia and implications for travel medicine, Journal of Travel Medicine, 2023

Nilles E, de St. Aubin M, Dumas D, Duke W, Etienne MC, Abdalla G, et al. Monitoring Temporal Changes in SARS-CoV-2 Spike Antibody Levels and Variant-Specific Risk for Infection, Dominican Republic, March 2021–August 2022. Emerging Infectious Disease journal. 2023;29(4).

Assoum, M.; Lau, C.L.; Thai, P.K.; Ahmed, W.; Mueller, J.F.; Thomas, K.V.; Choi, P.M.; Jackson, G.; Selvey, L.A. Wastewater Surveillance Can Function as an Early Warning System for COVID-19 in Low-Incidence Settings. Trop. Med. Infect. Dis. 2023, 8, 211. https://doi.org/10.3390/tropicalmed8040211

Lau CL, Mills DJ, Mayfield H, Gyawali N, Johnson BJ, Lu H, et al. A decision support tool for risk–benefit analysis of Japanese encephalitis vaccine in travellers. Journal of Travel Medicine. 2023.

Cavany S, Nanyonga S, Hauk C, Lim C, Tarning J, Sartorius B, Dolecek C, Caillet C, Newton PN, Cooper BS. The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance. Nature Communications. 2023 Oct 3;14(1):6153.

Rees EM, Lau CL, Kama M, Reid S, Lowe R, Kucharski AJ. Estimating the duration of antibody positivity and likely time of Leptospira infection using data from a cross-sectional serological study in Fiji. PLOS Neglected Tropical Diseases. 2022. 

Bragazzi Nicola Luigi, Woldegerima Woldegebriel Assefa, Iyaniwura Sarafa Adewale, Han Qing, Wang Xiaoying, Shausan Aminath, e tal. Knowing the unknown: The underestimation of monkeypox cases. Insights and implications from an integrative review of the literature. Frontiers in Microbiology, 2022. https://doi.org/10.3389/fmicb.2022.1011049 

Nilles, E. J., Paulino, C. T., de St. Aubin, M., Restrepo, A. C., Mayfield, H., Dumas, D., . . . Lau, C. L. (2022). SARS-CoV-2 seroprevalence, cumulative infections, and immunity to symptomatic infection – A multistage national household survey and modelling study, Dominican Republic, June–October 2021. The Lancet Regional Health - Americas, 16, 100390. doi:https://doi.org/10.1016/j.lana.2022.100390

Nilles, E. J., Aubin, M. D. S., Dumas, D., Duke, W., Etienne, M. C., Abdalla, G., . . . Paulino, C. T. (2022). Integrated SARS-CoV-2 serological and virological screening across an acute fever surveillance platform to monitor temporal changes in anti-spike antibody levels and risk of infection during sequential waves of variant transmission — Dominican Republic, March 2021 to August 2022. medRxiv. doi:10.1101/2022.10.24.22281399

Stanhope J*, Mayfield HJ*, Guillaume JHA, Sahin O, Weinstein P, Lau CL. Synergising decision making and interventions across human health and environment: concepts for designing ana model for infectious disease transmission modeldiseases.  Socio-Environmental Systems Modelling, 3, 18126. https://doi.org/10.18174/sesmo.18126

 

Field E., Dyda, A. Lau CL.,The Medical Journal of Australia ; 214 (8): 386-386.e1.  doi: 10.5694/mja2.51019

Curtis SJ, Cutcher Z, Brett JA, Burrell S, Richards MJ, Hennessy D, Gang RF, Lau CL, Rowe SL. An evaluation of enhanced surveillance of hospitalised COVID-19 patients to inform the public health response in Victoria. Communicable Disease Intellgence 2021. doi: https://doi.org/10.33321/cdi.2020.44.98

McLure A, Lau CL, Furuya-Kanamori L. Has the effectiveness of Australia’s travel bans against China on the importation of COVID-19 been overestimated? Journal of Travel Medicine. 2020;28(2). doi: 10.1093/jtm/taaa191.

Cadavid Restrepo A, Furuya-Kanamori L, Mayfield H, Nilles E, Lau CL. Implications of a travel connectivity-based approach for infectious disease transmission risks in Oceania. BMJ Open. 2021;11(8):e046206. doi: 10.1136/bmjopen-2020-046206.

Dyda A, Fahim M, Fraser J, Kirrane M, Wong I, McNeil K, Ruge M, Lau CL, Sullivan C. Managing the Digital Disruption Associated with COVID-19-Driven Rapid Digital Transformation in Brisbane, Australia. Applied clinical informatics. 2021;12(5):1135-43. Epub 2021/12/02. doi: 10.1055/s-0041-1740190. PubMed PMID: 34852391; PubMed Central PMCID: PMCPMC8636016.

Field E, Dyda A, Hewett M, Weng H, Shi J, Curtis S, Law C, McHugh L, Sheel M, Moore J, Furuya-Kanamori L, Pillai P, Konings P, Purcell M, Stocks N, Williams G, Lau CL. Development of the COVID-19 Real-Time Information System for Preparedness and Epidemic Response (CRISPER), Australia. Front Public Health. 2021;9:753493. Epub 2021/12/04. doi: 10.3389/fpubh.2021.753493. PubMed PMID: 34858930; PubMed Central PMCID: PMCPMC8631999.

Lau CL, Mayfield HJ, Sinclair JE, Brown SJ, Waller M, Enjeti AK, Baird A, Short K, Mengersen K, Litt J. Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework. Vaccine. 2021. doi: https://doi.org/10.1016/j.vaccine.2021.10.079.

Lau CL, Galea I. Risk–benefit analysis of COVID-19 vaccines — a neurological perspective. Nature Reviews Neurology. 2022;18(2):69-70. doi: 10.1038/s41582-021-00606-5.

Mayfield HJ, Lau CL, Sinclair JE, Brown SJ, Baird A, Litt J, Vuorinen A, Short KR, Waller M, Mengersen K. Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine. medRxiv. 2021:2021.10.28.21265588. doi: 10.1101/2021.10.28.21265588.

Neglected tropical diseases

Scott JL, Mayfield HJ, Sinclair J, Martin BM, Howlett M, Muttucumaru R, (…) Lau CL. Field comparison of STANDARD™ Q Filariasis Antigen Test (QFAT) with Bioline Filariasis Test Strip (FTS) for the detection of Lymphatic Filariasis in Samoa, 2023. PLOS NTDs, 2024. [Accepted]

Graves PM, Scott JL, Soto AB, Widi AY, Whittaker M, Lee D, Lau Colleen L., Won Kimberly Y. Laboratory Comparison of Rapid Antigen Diagnostic Tests for Lymphatic Filariasis: STANDARD<sup>TM</sup>Q Filariasis Antigen Test (QFAT) and Bioline Filariasis Test Strip (FTS). 2024. [preprint]

Scott JL, Mayfield HJ, Sinclair J, Martin BM, Howlett M, Muttucumaru R, (…) Lau CL. Field comparison of STANDARD™ Q Filariasis Antigen Test (QFAT) with Bioline Filariasis Test Strip (FTS) for the detection of Lymphatic Filariasis in Samoa, 2023. 2024. [preprint]

Howlett M, Mayfield H, McPherson B, Rigby L, Thomsen R, Williams SA, (…) Lau CL. Molecular xenomonitoring as an indicator of microfilaraemia prevalence for lymphatic filariasis in Samoa in 2019. 2024.

Helen J Mayfield, Benn Sartorius, Sarah Sheridan, Maddison Howlett, Beatris Mario Martin, Robert Thomsen, Rossana Tofaeono-Pifeleti, Satupaitea Viali, Patricia M Graves, Colleen L Lau. Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug administration. PLOS NTDs. https://doi.org/10.1371/journal.pntd.0012236

Wang Q, Ma T, Ding F, Lim A, Takaya S, Saraswati K, Sartorius B, Day NP, Maude RJ. Global and Regional Seroprevalence, Incidence, Mortality of, and Risk Factors for Scrub Typhus: A Systematic Review and Meta-Analysis. Incidence, Mortality of, and Risk Factors for Scrub Typhus: A Systematic Review and Meta-Analysis. International Journal of Infectious Diseases. 2024, online 2 July. https://doi.org/10.1016/j.ijid.2024.107151

Lawford H, Tukia O, Takai J, Sheridan S, Lau C. Operational research to inform post-validation surveillance of lymphatic filariasis in Tonga study protocol: history of lymphatic filariasis elimination, rational, objectives, and design. PLoS ONE.  [Accepted].

Gilmour B, Wangdi K, Restrepo AC, Tsheten T, Kelly M, Clements A, Gray D, Lau C, et al. Protocol for spatial prediction of soil transmitted helminth prevalence in the Western Pacific region using a meta-analytical approach. Systematic Reviews. 2024;13(1)

Adam Craig, Nixon Panda, Rudgard Palapu, Geoffrey Oku, Clement Lifoia, Joanna Tatalu, Nigel Beebe, Gerard Kelly, Nathan Kama Jr, Charlie Iro’ofa, Hugo Bugoro. Citizen Science for Enhanced Dengue Vector Surveillance in Solomon Islands: A Methods Paper. Cit Sci Theory & Prac.

Sohail A, Barry A, Auburn S, Cheng Q, Lau CL, Lee R, et al. Imported malaria into Australia: surveillance insights and opportunities. Journal of Travel Medicine. 2023. https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taad164/7486528?login=true

Dove G, Kelly-Hanku A, Usurup J, O’Keeffe, Scahill G, Craig A. Collaboration in a partnership for primary health care: a case study from Papua New Guinea. Glob Health Sci Pract. 2024;12(1):e2300040. https://doi.org/10.9745/GHSP-D-23-00040

McLure A, Graves PM, Lau C, Shaw C, Glass K. Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration. Epidemics. 2022:100591.

Dickson, B.F.R.; Masson, J.J.R.; Mayfield, H.J.; Aye, K.S.; Htwe, K.M.; Roineau, M.; Andreosso, A.; Ryan, S.; Becker, L.; Douglass, J.; Graves, P.M. Bayesian Network Analysis of Lymphatic Filariasis Serology from Myanmar Shows Benefit of Adding Antibody Testing to Post-MDA Surveillance. Trop. Med. Infect. Dis. 2022, 7, 113. https://doi.org/10.3390/tropicalmed7070113

McPherson, B.; Mayfield, H.J.; McLure, A.; Gass, K.; Naseri, T.; Thomsen, R.; Williams, S.A.; Pilotte, N.; Kearns, T.; Graves, P.M.; Lau, C.L. Evaluating Molecular Xenomonitoring as a Tool for Lymphatic Filariasis Surveillance in Samoa, 2018–2019. Trop. Med. Infect. Dis. 2022, 7, 203. https://doi.org/10.3390/tropicalmed7080203. 

Assoum, M.; Ortu, G.; Basáñez, M.-G.; Lau, C.; Clements, A.C.A.; Halton, K.; Fenwick, A.; Magalhães, R.J.S. Impact of a 5-Year Mass Drug Administration Programme for Soil-Transmitted Helminthiases on the Spatial Distribution of Childhood Anaemia in Burundi from 2007 to 2011. Trop. Med. Infect. Dis. 2022, 7, 307. https://doi.org/10.3390/tropicalmed7100307

Lemin, M.E.; Cadavid Restrepo, A.; Mayfield, H.J.; Lau, C.L. Spatially Explicit Environmental Factors Associated with Lymphatic Filariasis Infection in American Samoa. Trop. Med. Infect. Dis. 2022, 7, 295. https://doi.org/10.3390/tropicalmed7100295

Wangdi K, Sheel M, Fuimaono S, Graves PM, Lau CL. Lymphatic filariasis in 2016 in American Samoa: Identifying clustering and hotspots using non-spatial and three spatial analytical methods. PLoS Negl Trop Dis. 2022;16(3):e0010262.

McPherson B,  Mayfield HJ, McLure A, Gass K,  Naseri T, Thomsen R,  Williams S, Pilotte R, Kearns T, Graves PM, Lau CL. Molecular xenomonitoring as a complement to human antigen seroprevalence for lymphatic filariasis surveillance in Samoa. Research Square 2022.  10.21203/rs.3.rs-1294399/v1

Sheel M, Lau CL, Sheridan S, Fuimaono S, Graves PM. Comparison of Immunochromatographic Test (ICT) and Filariasis Test Strip (FTS) for Detecting Lymphatic Filariasis Antigen in American Samoa, 2016. Tropical Medicine and Infectious Disease. 2021;6(3):132. PubMed PMID: doi:10.3390/tropicalmed6030132.

Graves PM, Sheridan S, Scott J, Amosa-Lei Sam F, Naseri T, Thomsen R, King CL, Lau CL. Triple-Drug Treatment Is Effective for Lymphatic Filariasis Microfilaria Clearance in Samoa. Tropical Medicine and Infectious Disease. 2021;6(2):44. PubMed PMID: doi: 10.3390/tropicalmed6020044.

Graves PM, Joseph H, Coutts SP, Mayfield HJ, Maiava F, Ah Leong-Lui TA, Tupuimatagi Toelupe P, Toeaso Iosia V, Loau S, Pemita P, Naseri T, Thomsen R, Berg Soto A, Burkot TR, Wood P, Melrose W, Aratchige P, Capuano C, Kim SH, Ozaki M, et al. Control and elimination of lymphatic filariasis in Oceania: Prevalence, geographical distribution, mass drug administration, and surveillance in Samoa, 1998-2017. Advances in parasitology. 2021;114:27-73. Epub 2021/10/27. doi: 10.1016/bs.apar.2021.03.002. PubMed PMID: 34696844.

Henderson AD, Kama M, Aubry M, Hue S, Teissier A, Naivalu T, Bechu VD, Kailawadoko J, Rabukawaqa I, Sahukhan A, Hibberd ML, Nilles EJ, Funk S, Whitworth J, Watson CH, Lau CL, Edmunds WJ, Cao-Lormeau V-M, Kucharski AJ. Interactions between timing and transmissibility explain diverse flavivirus dynamics in Fiji. Nature Communications. 2021;12(1):1671. doi: 10.1038/s41467-021-21788-y.

Aw JYH, Clarke NE, Mayfield HJ, Lau CL, Richardson A, Vaz Nery S. Novel statistical approaches to identify risk factors for soil-transmitted helminth infection in Timor-Leste. International Journal for Parasitology. 2021;51(9):729-39. doi: https://doi.org/10.1016/j.ijpara.2021.01.005.

Hedtke SM, Zendejas-Heredia PA, Graves PM, Sheridan S, Sheel M, Fuimaono SD, Lau CL, Grant WN. Genetic epidemiology of lymphatic filariasis in American Samoa after mass drug administration. International Journal for Parasitology. 2021;51(2):137-47. doi: https://doi.org/10.1016/j.ijpara.2020.08.009.

Suwannatrai AT, Thinkhamrop K, Suwannatrai K, Pratumchart K, Wangdi K, Kelly M, Cadavid Restrepo, A, Gray DJ, Clements ACA, Tangkawattana S. Opisthorchis viverrini and Strongyloides stercoralis mono-and co-infections: Bayesian geostatistical analysis in an endemic area, Thailand. Acta tropica. 2021;223:106079. doi: https://doi.org/10.1016/j.actatropica.2021.106079

Cadavid Restrepo A, Gass K, Won KY, Sheel M, Robinson K, Graves PM, Fuimaono S, Lau CL. Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post-mass drug administration surveillance, American Samoa. MedRxiv. 2021. doi: doi.org/10.1101/2021.11.29.21267031 

McPherson B,  Mayfield HJ, McLure A, Gass K,  Naseri T, Thomsen R,  Williams S, Pilotte R, Kearns T, Graves PM, Lau CL. Molecular xenomonitoring as a complement to human antigen seroprevalence for lymphatic filariasis surveillance in Samoa. Research Square 2022.  doi: 10.21203/rs.3.rs-1294399/v1

Vaccine preventable diseases

Garnier, S., Then, C., De St Aubin, M., Cadavid Restrepo, A., Mayfield, H.J., Dumas, D., Duke, W., Peña, F., Kucharski, A.J., Skewes, R., Zielinski Gutiérrez, E., Coyoli, J., Etienne, M.C., Lau, C.L., Vázquez, M., Nilles, E., 2024. Trust and COVID-19 vaccine hesitancy in the Dominican Republic: a national cross-sectional household survey, June–October 2021. BMJ Open 14, e081523.. https://doi.org/10.1136/bmjopen-2023-081523

Antimicrobial resistance

Wen SC, Harris PNA, Forde B, Permana B, Chatfield MD, Lau CL, et al. Characterization of gram-negative bloodstream infections in hospitalised Australian children and their clinical outcomes. Clinical Infectious Diseases. 2024. https://doi.org/10.1093/cid/ciae341 [EDITOR’S CHOICE]

Venkateswaran N, Swetschinski L, Fastl C, Criscuolo N, Mulchandani R, Zhao C, Meštrović T, Ikuta K, Martin S, Coyne L, Afonso J, Huntington B, Rushton J, Devleesschauwer B, Sartorius B, Van Boeckel T, Pigott D (2024). Using Priorities between Human and Livestock Bacterial Antimicrobial Resistance (AMR) to Identify Data Gaps in Livestock AMR Surveillance, 17 April 2024, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-4253597/v1]. Under review: BMJ Global Health.

GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators [Sartorius B]. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021 (2024). The Lancet Infectious Diseases. Published Apr 15, 2024 [https://doi.org/10.1016/S1473-3099(24)00176-2].

Hasan, M., Talukder, S., Mandal, A.K., Tasmim, S.T., Parvin, S., Ali, Y., Sikder, M.H., Callaghan, T.J., Soares Magalhães, R.J., Islam, T., 2024. Antimicrobial Resistance Profiles of Campylobacter spp. Recovered from Chicken Farms in Two Districts of Bangladesh. Foodborne Pathogens and Disease.. https://doi.org/10.1089/fpd.2023.0079

Social/Implementation science

Jaworski, A.; Craig, A.; Dyer, C.; Goncalves, G.; Newland, J.; Kelly, A.; Pomat, W.; MacLaren, D.; Vas Nery, S. Understanding how neglected tropical diseases programs in five Asia-Pacific countries adjusted to the COVID-19 pandemic: A qualitative study. PLOS Neglected Tropical Diseases. In press.

Dove, G.; Sachill, G.; Roxas, B.; Kelly, A; Craig, A. Collaborative governance in a primary health care partnership in Papua New Guinea. Int J Hlth Planing Mment. (In press)

Methodological work

Kingsbury C, Buzzi M, Chaix B, Kanning M, Khezri S, Kiani B, et al. STROBE-GEMA: a STROBE extension for reporting of geographically explicit ecological momentary assessment studies. Archives of Public Health. 2024;82(1)

Other

Ratnayake H, Ogeboye O, Pak A, Eisen D, McBryde E. Bacteraemia in Tropical Australia: A Review. Current tropical medicine reports, 2024. [Accepted]

Santos GS, Macedo VACF, Reikdal SO, Martin, BM, Graf ME, Meier, MJ,  Ventilator-associated pneumonia risk factors in patients with severe COVID-19 in southern Brazil: a retrospective observational study. Infection, Disease & Health, 2024 [Accepted]

Endalamaw, A., Gilks, C.F., Ambaw, F. Shiferaw W.S, Assefa Y.. Explaining inequity in knowledge, attitude, and services related to HIV/AIDS: a systematic review. BMC Public Health 24, 1815 (2024). https://doi.org/10.1186/s12889-024-19329-5

Belete AM, Melese DM, Bewket B, Tegegne B, Shiferaw WS, Aynalem YA, et al. Dyslipidemia among adult HIV patients on antiretroviral therapy and its association with age and body mass index in Ethiopia: A systematic review and meta-analysis. PLoS One. 2024;19(5):e0298525.

Mathoma A, Sartorius B, Mahomed S (2024). Evaluation of cancer screening services by healthcare professionals for people living with HIV in Botswana. Accepted: Health Promotion International.

IHME Pathogen Core Group [Sartorius B]. Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2024). The Lancet Infectious Diseases. Published Apr 16, 2024 [https://doi.org/10.1016/S1473-3099(24)00158-0].

Nasser A, de Zwart BJ, Stewart DJ, Zielke AM, Blazek K, Heywood AE, Craig AT. Risk factors predicting the need for intensive care unit admission within forty-eight hours of emergency department presentation: A case-control study. Aust Crit Care. 2024 Apr 6:S1036-7314(24)00028-6. doi: 10.1016/j.aucc.2024.01.012. Epub ahead of print. PMID: 38584063

Mathoma A, Sartorius B, Mahomed S. The Trends and Risk Factors of AIDS-Defining Cancers and Non-AIDS-Defining Cancers in Adults Living with and without HIV: A Narrative Review. Journal of Cancer Epidemiology. 2024 Mar 21;2024. https://doi.org/10.1155/2024/7588928. 

Mathoma A, Sartorius B, Mahomed S (2024). The trends and risk factors of AIDS Defining Cancers and non-AIDS Defining Cancers in adults living with and without HIV: A narrative review. Accepted: Journal of Cancer Epidemiology.

Tadese, M., Endale, A., Asegidew, W., Tessema, S. D., & Shiferaw, W. S. (2024). Nursing patient record practice and associated factors among nurses working in North Shewa Zone public hospitals, Ethiopia. Frontiers in Health Services, 4, 1340252. https://doi.org/10.3389/frhs.2024.1340252

Behzad Kiani, Benn Sartorius, Colleen L Lau, Robert Bergquist. Mastering Geographically Weighted Regression: Key Considerations for Building a Robust Model, Geospatial Health Journal, 2024.

Browne A,…[62 authors], Sartorius B, Dolecek C. Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990–2019: a modelling study. The Lancet Global Health, 2024; 12: e406–18.

Dove, G.; Kelly-Hanku, A.; Usurup, J.; O’Keeffe, A.; Scahill, G.; Craig, A. Collaboration in a partnership for primary health care: a case study from Papua New Guinea. Global Health: Science and Practice, 2023.

Gilmour B, Wangdi K, Restrepo AC, Tsheten T, Kelly M, Clements A, Gray D, Lau C et al. Protocol for spatial prediction of soil transmitted helminth prevalence in the Western Pacific region using a meta-analytical approach. Systematic Reviews. 2024;13(1).

Ahmad Nasser, Blake de Zwart, Anne Zielke, Katrina Blazek, Anita Heywood, Adam Craig. Risk Factors Predicting the Need for Intensive Care Unit Admission within Forty-Eight Hours of Emergency Department Presentation. Aust Crit Care,

Integrated strategies for disease surveillance in the Pacific Islands – Niue 

This formative research project aims to investigate the prevalence of Lymphatic filariasis, and other eliminated, near-eliminated and priority neglected tropical, vaccine-preventable and vector-borne diseases in Niue In addition, it will attempt to define what factors support the efficient, effective and sustainable implementation of integrated infectious disease surveillance in Pacific Island settings, as well as determine the costs of implementing integrated surveillance compared to disease-specific approaches.  

Lead: Dr Adam Craig, Senior Research Fellow, Operational Research and Decision Support for Infection Diseases (ODeSI) Program, The University of Queensland, Brisbane, Australia 

The GSK Immunisation Awards have been developed to reward innovation that improves coverage and timely delivery of childhood, adolescent and adult immunisation.  This year’s four winners were announced at the 2024 Communicable Diseases & Immunisation Conference dinner on June 12, 2024. Dr Luis Furuya Kanamori led a team which also included Prof Colleen Lau, Dr Helen Mayfield, Mr Wondimeneh Shiferaw and Dr Hongen Lu from UQ and external co-investigators Dr Deborah Mills, Dr Brian Johnson, Dr Narayan Gyawali, Dr Yan Zhu, Dr Sarah McGuinness, and Dr Jenny Visser. The team will use the Award to develop a Risk-Benefit Analysis Tool for Yellow Fever (YF) Vaccine. YF continues to affect over 100,000 individuals annually in endemic areas, and poses a significant risk to unvaccinated international travellers to South America and Africa (170/100,000 YF cases per month of travel, with 40% case-fatality rate).